CN104364329B - 包含有机稀释剂和纤维素醚的组合物 - Google Patents
包含有机稀释剂和纤维素醚的组合物 Download PDFInfo
- Publication number
- CN104364329B CN104364329B CN201380030562.4A CN201380030562A CN104364329B CN 104364329 B CN104364329 B CN 104364329B CN 201380030562 A CN201380030562 A CN 201380030562A CN 104364329 B CN104364329 B CN 104364329B
- Authority
- CN
- China
- Prior art keywords
- methyl
- cellulose ether
- anhydroglucose unit
- fluid composition
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
- C08L1/28—Alkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
- C08L1/28—Alkyl ethers
- C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
- C09D101/08—Cellulose derivatives
- C09D101/26—Cellulose ethers
- C09D101/28—Alkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
- C09D101/08—Cellulose derivatives
- C09D101/26—Cellulose ethers
- C09D101/28—Alkyl ethers
- C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals
Abstract
Description
碳原子的类型 | ECN增量 |
烃 | 100 |
伯醇 | 55 |
仲醇 | 45 |
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261622757P | 2012-04-11 | 2012-04-11 | |
US61/622,757 | 2012-04-11 | ||
PCT/US2013/035592 WO2013154980A1 (en) | 2012-04-11 | 2013-04-08 | Composition comprising an organic diluent and a cellulose ether |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104364329A CN104364329A (zh) | 2015-02-18 |
CN104364329B true CN104364329B (zh) | 2016-08-17 |
Family
ID=48142997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380030562.4A Expired - Fee Related CN104364329B (zh) | 2012-04-11 | 2013-04-08 | 包含有机稀释剂和纤维素醚的组合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9757465B2 (zh) |
EP (1) | EP2836559B1 (zh) |
JP (1) | JP6185559B2 (zh) |
KR (1) | KR102065326B1 (zh) |
CN (1) | CN104364329B (zh) |
BR (1) | BR112014021506B1 (zh) |
PT (1) | PT2836559T (zh) |
WO (1) | WO2013154980A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9591870B2 (en) * | 2011-06-14 | 2017-03-14 | Dow Global Technologies Llc | Food composition comprising a cellulose ether |
US9441117B2 (en) | 2012-03-20 | 2016-09-13 | Basf Se | Mixtures, methods and compositions pertaining to conductive materials |
CN104602673B (zh) * | 2012-07-17 | 2017-11-24 | 陶氏环球技术有限责任公司 | 包含高度取代的羟基烷基甲基纤维素的固体分散体 |
BR112015019577B1 (pt) * | 2013-04-12 | 2022-02-08 | Nutrition & Biosciences Usa 1, Llc | Processo para preparar uma solução aquosa de uma metilcelulose, solução aquosa de uma metilcelulose livre de proteínas e medicamento, alimento, ingrediente de alimento ou suplemento alimentício |
KR101740300B1 (ko) * | 2013-07-17 | 2017-05-26 | 다우 글로벌 테크놀로지스 엘엘씨 | 히드록시알킬 메틸셀룰로스를 포함하는 점막으로의 적용을 위한 조성물 |
WO2015047763A1 (en) * | 2013-09-25 | 2015-04-02 | Dow Global Technologies Llc | Composition comprising an organic liquid diluent and a specific hydroxyalkyl methylcellulose |
WO2015108768A1 (en) * | 2014-01-16 | 2015-07-23 | Dow Global Technologies Llc | Support materials for 3d printing |
BR112017024993A2 (pt) | 2015-06-05 | 2018-08-07 | Dow Global Technologies Llc | ?método para produção de éter tipo metilcelulose em forma de pó?. |
BR112017025103B1 (pt) * | 2015-06-05 | 2022-05-10 | Nutrition & Biosciences Usa 1, Llc | Composição em pó |
US10201933B2 (en) * | 2015-06-09 | 2019-02-12 | Dow Global Technologies Llc | Support materials for 3D printing |
CN113637088B (zh) * | 2021-10-18 | 2021-12-24 | 高密银鹰新材料股份有限公司 | 一种减少纤维素醚生产过程中产生黑黄点的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723151A (en) * | 1995-11-06 | 1998-03-03 | Eastman Chemical Company | Cellulose acetate phthalate enteric coating compositions |
CN101203223A (zh) * | 2005-02-24 | 2008-06-18 | 史密丝克莱恩比彻姆公司 | 包括无定形罗格列酮的药物组合物 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2613142A (en) | 1948-05-11 | 1952-10-07 | Sol B Wiczer | Alcohol fuel gel |
US3477864A (en) * | 1965-05-07 | 1969-11-11 | Sumitomo Chemical Co | Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film |
GB1144225A (en) | 1965-09-07 | 1969-03-05 | Dow Chemical Co | Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers |
DE2917104A1 (de) | 1979-04-27 | 1980-11-06 | Hoechst Ag | Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung |
JPS6225101A (ja) | 1985-07-24 | 1987-02-03 | Shin Etsu Chem Co Ltd | 低重合度セルロ−スエ−テルの製造方法 |
GB8608080D0 (en) * | 1986-04-02 | 1986-05-08 | Fujisawa Pharmaceutical Co | Solid dispersion composition |
EP0872233A1 (en) | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Antiretroviral compositions with improved bioavailability |
US6261218B1 (en) | 1998-12-01 | 2001-07-17 | The Dow Chemical Company | Process and apparatus for making low molecular weight cellulose ethers |
US6235893B1 (en) * | 1999-04-01 | 2001-05-22 | The Dow Chemical Company | Process for making cellulose ether having enhanced gel strength |
MXPA02003182A (es) * | 1999-09-24 | 2002-09-30 | Janssen Pharmaceutica Nv | Composiciones antivirales. |
KR20010097244A (ko) | 2000-04-21 | 2001-11-08 | 유충식 | 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법 |
DE10038978A1 (de) * | 2000-08-10 | 2002-02-21 | Wolff Walsrode Ag | Verfahren zur Herstellung von Alkylhydroxyalkylcellulose |
DE10141680B4 (de) | 2001-08-25 | 2004-02-26 | Clariant Gmbh | Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern |
DE10233788A1 (de) * | 2002-07-25 | 2004-02-05 | Wolff Cellulosics Gmbh & Co. Kg | Cellulosederivate mit gel-artigen rheologischen Eigenschaften und Verfahren zur Herstellung derselben |
US7666918B2 (en) | 2004-03-17 | 2010-02-23 | Dow Global Technologies, Inc. | Foams made from interpolymers of ethylene/α-olefins |
DE602005010074D1 (de) * | 2004-05-28 | 2008-11-13 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer |
MY148074A (en) * | 2005-05-10 | 2013-02-28 | Novartis Ag | Pharmaceutical compositions comprising imatinib and a release retardant |
CA2664326C (en) * | 2006-09-29 | 2016-01-19 | Union Carbide Chemicals & Plastics Technology Corporation | Quaternized cellulose ethers for personal care products |
US8372836B2 (en) * | 2006-10-17 | 2013-02-12 | Bend Research, Inc. | Spray dried formulation |
US20080262216A1 (en) * | 2007-04-20 | 2008-10-23 | Shin-Etsu Chemical Co., Ltd. | Hydroxyalkyl methylcellulose having solubility and thermoreversible gelation properties improved |
CN103261233B (zh) * | 2010-10-12 | 2016-05-25 | 陶氏环球技术有限责任公司 | 新的纤维素醚以及它们的用途 |
JP2014505054A (ja) * | 2011-01-10 | 2014-02-27 | セルジーン コーポレイション | シクロプロパンカルボン酸{2−[(1s)−1−(3−エトキシ−4−メトキシ−フェニル)−2−メタンスルホニル−エチル]−3−オキソ−2,3−ジヒドロ−1h−イソインドール−4−イル}−アミドの経口剤形 |
BR112014020719B1 (pt) * | 2012-04-11 | 2020-03-03 | Dow Global Technologies Llc | Forma de dosagem de liberação constante, método para preparar uma forma de dosagem de liberação constante e uso de um éter de celulose |
-
2013
- 2013-04-08 PT PT137176772T patent/PT2836559T/pt unknown
- 2013-04-08 BR BR112014021506-5A patent/BR112014021506B1/pt not_active IP Right Cessation
- 2013-04-08 EP EP13717677.2A patent/EP2836559B1/en not_active Not-in-force
- 2013-04-08 JP JP2015505827A patent/JP6185559B2/ja not_active Expired - Fee Related
- 2013-04-08 KR KR1020147031595A patent/KR102065326B1/ko active IP Right Grant
- 2013-04-08 CN CN201380030562.4A patent/CN104364329B/zh not_active Expired - Fee Related
- 2013-04-08 WO PCT/US2013/035592 patent/WO2013154980A1/en active Application Filing
- 2013-04-08 US US14/390,049 patent/US9757465B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723151A (en) * | 1995-11-06 | 1998-03-03 | Eastman Chemical Company | Cellulose acetate phthalate enteric coating compositions |
CN101203223A (zh) * | 2005-02-24 | 2008-06-18 | 史密丝克莱恩比彻姆公司 | 包括无定形罗格列酮的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
KR102065326B1 (ko) | 2020-01-13 |
WO2013154980A1 (en) | 2013-10-17 |
EP2836559A1 (en) | 2015-02-18 |
CN104364329A (zh) | 2015-02-18 |
BR112014021506B1 (pt) | 2020-06-16 |
KR20140144297A (ko) | 2014-12-18 |
PT2836559T (pt) | 2016-08-31 |
JP2015512941A (ja) | 2015-04-30 |
JP6185559B2 (ja) | 2017-08-23 |
US9757465B2 (en) | 2017-09-12 |
US20150065548A1 (en) | 2015-03-05 |
EP2836559B1 (en) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104364329B (zh) | 包含有机稀释剂和纤维素醚的组合物 | |
CN104364268B (zh) | 包含纤维素醚的熔融挤出的组合物 | |
CN104427979B (zh) | 具有特定的取代基分布的酯化的纤维素醚 | |
KR102160903B1 (ko) | 고도로 치환된 하이드록시알킬 메틸셀룰로즈를 포함하는 고체 분산물 | |
EP2694110B2 (en) | Novel polysaccharide derivatives and dosage forms | |
US11000594B2 (en) | Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity | |
US20150320869A1 (en) | Composition comprising an organic liquid diluent and a specific hydroxypropyl methylcellulose | |
JP6353061B2 (ja) | 有機液体希釈剤及び特定のヒドロキシアルキルメチルセルロースを含む組成物 | |
EP3466411A1 (en) | Method for producing pharmaceutical composition containing microparticles of sparingly-soluble drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Delaware, USA Patentee after: DDP special electronic materials USA Co.,Ltd. Address before: Delaware, USA Patentee before: DDP special electronic materials American Co. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210728 Address after: michigan Patentee after: THE DOW CHEMICAL Co. Address before: michigan Patentee before: DOW GLOBAL TECHNOLOGIES LLC Effective date of registration: 20210728 Address after: Delaware, USA Patentee after: DDP special electronic materials American Co. Address before: michigan Patentee before: THE DOW CHEMICAL Co. Effective date of registration: 20210728 Address after: New York, United States Patentee after: Nutrition and biotechnology USA first LLC Address before: Delaware, USA Patentee before: DDP special electronic materials USA Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 Termination date: 20210408 |